Literature DB >> 20459569

Clonality of nodular lesions in liver cirrhosis and chromosomal abnormalities in monoclonal nodules of altered hepatocytes.

Li Gong1, Yan-Hong Li, Qin Su, Xia Chu, Wei Zhang.   

Abstract

AIMS: To investigate the clonality and chromosome abnormalities of nodules of altered hepatocytes (NAH) in liver cirrhosis and determine whether there is a genetic link between monoclonal NAH and hepatocellular carcinoma (HCC). METHODS AND
RESULTS: First, 93 nodules from nine hepatitis B virus (HBV)-related liver cirrhosis patients were dissected by laser microdissection. Next, genomic DNA was extracted, pretreated with Hpa II or Hha I, and amplified via nested polymerase chain reaction for the phosphoglycerate kinase and androgen receptor genes. Finally, the chromosomal aberrations of 12 monoclonal NAH were studied using array-based comparative genomic hybridization (array-CGH). Loss of X chromosomal inactivation mosaicism was demonstrated in three large regenerative nodules and 12 NAH with small cell change (SCC), indicating their neoplastic nature. Among the 60 NAH without SCC, 29 (48.33%) were shown to be monoclonal, whereas four glycogen-storing foci and 14 regenerative nodules were found to be polyclonal. Array-CGH analysis revealed chromosomal abnormalities in one NAH with SCC. Moreover, a part of chromosomal abnormalities in the NAH with SCC coincided with those in HCC.
CONCLUSIONS: Some (48.33%) NAH in HBV-associated cirrhosis, particularly all those with SCC, are already neoplastic lesions. Occurrence of SCC is a late event during NAH progression, suggesting a premalignant phenotype.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20459569     DOI: 10.1111/j.1365-2559.2010.03523.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  9 in total

1.  Glycogenotic hepatocellular carcinoma with glycogen-ground-glass hepatocytes: a heuristically highly relevant phenotype.

Authors:  Peter Bannasch
Journal:  World J Gastroenterol       Date:  2012-12-14       Impact factor: 5.742

2.  Genomic losses at 5q13.2 and 8p23.1 in dysplastic hepatocytes are common events in hepatitis B virus-related hepatocellular carcinoma.

Authors:  Zhang Zhao; Guang-Yong Chen; Jiang Long; Hai Li; Jian Huang
Journal:  Oncol Lett       Date:  2015-04-23       Impact factor: 2.967

3.  Evidence for heightened hexokinase II immunoexpression in hepatocyte dysplasia and hepatocellular carcinoma.

Authors:  Grace Guzman; Rohini Chennuri; Alexander Chan; Bryan Rea; Ada Quintana; Roshan Patel; Pei-Zhang Xu; Hui Xie; Nissim Hay
Journal:  Dig Dis Sci       Date:  2014-11-08       Impact factor: 3.199

4.  Somatic Mutations Increase Hepatic Clonal Fitness and Regeneration in Chronic Liver Disease.

Authors:  Min Zhu; Tianshi Lu; Yuemeng Jia; Xin Luo; Purva Gopal; Lin Li; Mobolaji Odewole; Veronica Renteria; Amit G Singal; Younghoon Jang; Kai Ge; Sam C Wang; Mahsa Sorouri; Justin R Parekh; Malcolm P MacConmara; Adam C Yopp; Tao Wang; Hao Zhu
Journal:  Cell       Date:  2019-04-04       Impact factor: 41.582

Review 5.  Androgen receptor roles in hepatocellular carcinoma, fatty liver, cirrhosis and hepatitis.

Authors:  Wen-Lung Ma; Hsueh-Chou Lai; Shuyuan Yeh; Xiujun Cai; Chawnshang Chang
Journal:  Endocr Relat Cancer       Date:  2014-05-06       Impact factor: 5.678

Review 6.  Latest developments in precancerous lesions of hepatocellular carcinoma.

Authors:  Zhao-Shan Niu; Xiao-Jun Niu; Wen-Hong Wang; Jing Zhao
Journal:  World J Gastroenterol       Date:  2016-03-28       Impact factor: 5.742

7.  Loss of heterozygosity at D8S262: an early genetic event of hepatocarcinogenesis.

Authors:  Qiao Zhu; Li Gong; Xiaoyan Liu; Jun Wang; Pin Ren; Wendong Zhang; Li Yao; Xiujuan Han; Shaojun Zhu; Miao Lan; Yanhong Li; Wei Zhang
Journal:  Diagn Pathol       Date:  2015-06-16       Impact factor: 2.644

Review 8.  Genetic Landscape of Multistep Hepatocarcinogenesis.

Authors:  Haruhiko Takeda; Atsushi Takai; Yuji Eso; Ken Takahashi; Hiroyuki Marusawa; Hiroshi Seno
Journal:  Cancers (Basel)       Date:  2022-01-23       Impact factor: 6.639

9.  Dysplastic nodules with glypican-3 positive immunostaining: a risk for early hepatocellular carcinoma.

Authors:  Li Gong; Long-Xiao Wei; Pin Ren; Wen-Dong Zhang; Xiao-Yan Liu; Xiu-Juan Han; Li Yao; Shao-Jun Zhu; Miao Lan; Yan-Hong Li; Wei Zhang
Journal:  PLoS One       Date:  2014-01-31       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.